Sanofi stock in India is trading slightly lower as of September 1, 2026, while the company manages a

Las acciones de Sanofi tienen un catalizador de vacunas reciente y un valor de mercado superior a los 100.000 millones de dólares, mientras que el último q

Sanofi shortfall triggers Korea flu vaccine shuffle as GC boosts NIP supply Private-market strain looms as Sanofi misses doses and GC reallocates stock to safeguard NIP

Sanofi stock maintains its large-cap valuation while trading below fair value estimates, as updated

Sanofi Korea said it held the Team Care Symposium (TreatmEnt InitiAtion for insulin needed dM patients), an academic symposium for healthcare professionals, at Le Méridien Seoul Myeongdong from Saturday to Sunday, bringing together Korean diabetes experts to discuss timely and individualized insulin

Sanofi stock is trading in the mid-$40s with a market value above $100 billion, while investors weig

Sanofi (ENXTPA:SAN) halted a Phase 3 RSV vaccine trial in infants and toddlers after the death of a participant linked to an undiagnosed congenital heart defect. The company reported an overall acceptable safety profile in the trial with no cases of vaccine associated enhanced respiratory disease identified. The pause has drawn attention to inclusion and exclusion criteria in pediatric vaccine studies and to how closely clinical trial protocols are followed. Regulators and investors are...

Sanofi (ENXTPA:SAN) has permanently halted its Phase 3 RSV vaccine trial in infants and toddlers following a serious adverse event involving an infant death. The death was later linked to an underlying health condition that should have excluded the child from the study, prompting questions about trial screening procedures. The decision has drawn heightened regulatory attention, including Freedom of Information Act requests to the FDA, and raises concerns about RSV vaccine safety in very...

Sanofi stock reflects a fresh FDA approval for its updated Nuvaxovid COVID-19 vaccine while earnings

The FDA has approved updated COVID vaccines for adults over age 65 and younger people with chronic conditions.

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Sanofi stock gains after the FDA cleared updated Covid vaccines for the 2026-27 season, while analys

Novavax, the Gaithersburg, Maryland-based vaccine company, announced on August 28, 2026 that its partners Sanofi and Takeda have secured approvals for an…